Adherence to subcutaneous interferon beta-1a treatment using an electronic injection device: a prospective open-label Scandinavian noninterventional study (the ScanSmart study)

BACKGROUND: Disease modifying drugs help control the course of relapsing remitting multiple sclerosis (RRMS); however, good adherence is needed for long-term outcomes. OBJECTIVE: To evaluate patient adherence to treatment with subcutaneous interferon beta-1a using RebiSmart(®) and assess injection-s...

Descripción completa

Detalles Bibliográficos
Autores principales: Pedersen, Elena Didenko, Stenager, Egon, Vadgaard, JL, Jensen, MB, Schmid, R, Meland, N, Magnussen, G, Frederiksen, Jette L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5916453/
https://www.ncbi.nlm.nih.gov/pubmed/29720872
http://dx.doi.org/10.2147/PPA.S154417

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5916453/
https://www.ncbi.nlm.nih.gov/pubmed/29720872
http://dx.doi.org/10.2147/PPA.S154417

Ejemplares similares